Executives in Ottawa have financial plans, strategic plans, succession plans and exit plans.
But very few have a biological runway plan.
In my clinical work, I regularly meet high-performing leaders in their 40s, 50s and early 60s who assume they are “fine.” They function at a high level, exercise occasionally and see their physician when something comes up.
What they don’t realize is that cardiovascular disease develops silently for decades. By the time symptoms appear, the disease is often advanced.
If you are a mid-career or senior leader in the National Capital Region, the most important plan you may be missing is your 20-year health plan.
The illusion of being fine
In Canada, routine annual physicals are no longer standard for otherwise healthy individuals. Most physicians appropriately focus on symptom-driven care and basic screening.
The problem? Cardiovascular disease, metabolic dysfunction and early cognitive risk rarely cause symptoms early on.
Standard cholesterol panels and blood pressure checks are not enough to identify:
- Subclinical coronary plaque
- Genetic lipid risk such as elevated Lipoprotein(a)
- Early insulin resistance
- Declining cardiorespiratory fitness
- Accelerated biological aging
Traditional healthcare is designed to treat disease once it declares itself. It is not structured to detect silent risk in high-functioning professionals.
Yet silent plaque commonly begins accumulating in the 40s and 50s — and sometimes earlier depending on genetic and metabolic risk markers.
Feeling well is not the same as being low risk.
Chronological age vs biological age
You may be 52 years old chronologically.
But what is the age of your cardiovascular system?
Biological age diverges from chronological age based on genetics, metabolic health, fitness capacity, sleep quality and inflammatory burden.
We now have tools to measure this more precisely. Coronary artery calcium (CAC) scoring, advanced lipid testing including ApoB and Lipoprotein(a), body composition analysis, VO₂ max testing and metabolic assessments provide a far clearer picture of long-term risk than basic screening alone.
These are evidence-based strategies that allow earlier, more precise intervention.
The objective is not simply to prevent a heart attack. It is to preserve vitality, cognitive performance and independence into your 70s and 80s.
What is missing from most executive health toolkits
A 20-year executive health framework should include five core elements:
1. Risk Clarity: Advanced cardiovascular imaging and biomarker testing to detect silent plaque and inherited risk.
2. Biological age awareness: Understanding whether your vascular system is aging faster than you are.
3. Metabolic optimization: Identifying insulin resistance, visceral fat and inflammatory drivers linked to cardiovascular disease, diabetes and dementia.
4. Fitness as a vital sign: Objective measurement of VO₂ max and body composition — powerful predictors of longevity and cognitive resilience.
5. Structured long-term follow-up: Reassessment every three to five years to monitor progression and adjust strategy proactively.
Most executives manage complex portfolios with precision. Very few manage their long-term biology with the same discipline.
That gap carries risk.
The leadership case for longevity
Cardiovascular health is not just about preventing heart attacks.
Vascular disease is a major contributor to cognitive decline and dementia. The same metabolic drivers that accelerate plaque formation — insulin resistance, chronic inflammation, poor sleep and inactivity — also impair brain function.
There is another reality: sudden cardiac death can occur in seemingly healthy middle-aged individuals without warning symptoms. Undetected plaque or structural abnormalities are often involved.
For leaders responsible for organizations, teams and families, reducing these risks is not just personal. It is strategic.
Longevity today means protecting cognitive capacity, decision-making ability and leadership runway.
A new model for proactive care in Ottawa
Ottawa’s business community is forward-thinking and data-driven. Healthcare should reflect that.
At Cardiac Longevity Clinic we have built Ottawa’s first and only cardiac-focused longevity clinic. Our model integrates advanced cardiovascular screening, metabolic assessment, lifestyle medicine and structured follow-up into a personalized long-term strategy.
We move beyond reactive, symptom-based care toward proactive, evidence-based risk reduction.
If you are between 40 and 65 and have never undergone advanced cardiovascular assessment, it may be time to ask a different question — not “Do I feel well?” but “Do I truly understand my risk for the next 20 years?”
The leaders who will thrive over the next two decades will not just be financially prepared.
They will be biologically prepared.
About the author
Dr. Behn Banihashemi is a cardiologist and founder of Cardiac Longevity Clinic, Ottawa’s first cardiac-focused longevity clinic. He specializes in proactive cardiovascular risk assessment, metabolic optimization and personalized longevity strategies for mid-career and senior leaders. His mission is to help patients reduce the risk of heart disease, cognitive decline and other age-related conditions through evidence-based preventive care.
